Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - authors' reply.
Bowman, Simon J Dorner, Thomas Mariette, Xavier Luo, Wen-Lin Hueber, Wolfgang
Bowman, Simon J
Dorner, Thomas
Mariette, Xavier
Luo, Wen-Lin
Hueber, Wolfgang
Abstract
No abstract available
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2022-09-10
Type
Article
Subject
Collections
Citation
Bowman SJ, Dorner T, Mariette X, Luo WL, Hueber W. Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - Authors' reply. Lancet. 2022 Sep 10;400(10355):808-809. doi: 10.1016/S0140-6736(22)01538-0